Clinical Trials
3 trialsNCT04375683 2022-03-24
Study of Efficacy and Safety of Flumatinib Combined With Chemotherapy in Ph Positive ALL
Zhongda Hospital
Phase 3 Unknown
NCT04677439 2022-03-16
Flumatinib in CML-CP Patients With Ph+ Post Imatinib Failure
Shenzhen Second People's Hospital
Phase 4 Unknown
NCT01503502 2013-04-10
A Phase II Study of Flumatinib Versus Imatinib to Treat Philadelphia Chromosome Positive Chronic Myelogenous Leukemia
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Unknown